1. Home
  2. Companies
  3. EMD
  4. Material Events

Emyria (ASX:EMD) — Material Events

ASX:EMD · 25 articles in the last 12 months · 100% assessed

Click a band to jump to that tier

Major 1 article Significant 22 articles Notable 2 articles Not Assessed 0 articles
Major ≥90 Significant 75–89 Notable 50–74 Routine <50 Not assessed
Significant Score 75–89
22
Emyria Accelerates National Expansion with $8M Placement and Victorian Clinic LaunchHigh
Emyria Accelerates National Clinic Expansion with $8M Placement and Victorian Empax Clinic Launch
20 Nov 2025 ·Capital Raising ·85
Emyria Advances Psychedelic Therapy Clinics with New Funding and Regulatory GainsMedium
Emyria updates on clinic progress, market opportunity, and funding in psychedelic-assisted therapy
11 June 2026 ·Company Update Presentation ·85
Emyria’s PTSD Treatment Yields Durable Recovery for Two-Thirds of PatientsMedium
Emyria's PTSD Program Achieves Durable Remission in Two-Thirds of Patients Over 12 Months
2 Feb 2026 ·ASX Announcement ·85
Emyria Accelerates National Clinic Rollout with Strong Revenue and Positive Depression DataMedium
Emyria expands national clinic network, reports strong revenue growth and positive early depression treatment outcomes
29 July 2026 ·Quarterly Activities and Cash Flow Report ·85
Emyria Accelerates National Rollout of Insurer-Funded PTSD and TRD TreatmentsMedium
Emyria expands insurer-funded PTSD and TRD programs nationally, reports strong revenue growth
27 Oct 2025 ·Quarterly Activity Report ·85
Emyria Advances National Clinic Network and Launches Global Partnership ProgramMedium
Emyria reports $1.2m revenue, expands national clinics, launches global partnership program
28 Apr 2026 ·Quarterly Activities and Cash Flow Report ·85
Emyria Accelerates National Empax Clinic Rollout with $8M Capital BoostMedium
Emyria advances national Empax clinic expansion with $8M raise and strong revenue growth
28 Jan 2026 ·Quarterly Activities and Cash Flow Report ·85
Emyria Accelerates National Clinic Expansion with 136% Revenue SurgeMedium
Emyria reports 136% revenue growth and $2.37M loss amid national clinic expansion and insurer funding
26 Feb 2026 ·Appendix 4D Half-year report ·85
Emyria Launches Global Services Platform to Unlock Psychedelic Therapy MarketMedium
Emyria launches global clinical services platform for psychedelic drug sponsors
20 Apr 2026 ·Corporate Announcement ·85
Emyria revenue jumps 191% as Sydney clinic nears launchMedium
Emyria reports strong FY26 growth as psychedelic therapy clinic network expands
8 Sept 2026 ·Investor Presentation ·82
Emyria Expands Empax Network with First Victorian Clinic ActivationMedium
Emyria Launches First Victorian Empax Clinic, Expands Mental Health Treatment Network
18 May 2026 ·Operational Update ·80
Emyria Expands Empax Clinics to New South Wales with Matilda PartnershipMedium
Emyria Expands National Mental Health Clinic Network into New South Wales with Matilda Healthcare Partnership
29 Apr 2026 ·Partnership Announcement ·80
Emyria and Medibank Expand Insurer-Backed Mental Health Care to VictoriaMedium
Emyria and Medibank expand insurer-backed mental health programs to Victoria
16 Feb 2026 ·ASX Announcement ·80
Emyria Expands National Reach with First Victorian Empax ClinicMedium
Emyria Secures First Victorian Empax Clinic, Expands National Mental Health Clinic Network
16 Dec 2025 ·ASX Announcement ·80
Emyria wins rare speaking slot at FDA psychedelic medicines hearingMedium
Emyria selected to address FDA hearing on psychedelic medicines
10 Sept 2026 ·Corporate Update ·Unexpected ·78
Emyria Accelerates NSW Expansion with New Clinical Recruitment DriveMedium
Emyria launches NSW clinical recruitment to accelerate national mental health expansion
2 Apr 2026 ·ASX Announcement ·75
TGA Expands Therapist Eligibility to Accelerate Emyria’s Empax Clinic RecruitmentMedium
TGA expands therapist eligibility to accelerate Emyria's Empax clinic recruitment
28 May 2026 ·Regulatory Update ·75
Emyria’s Victorian Empax Clinic Set to Launch in Q2 2026 with Strong Workforce and Funding SupportMedium
Emyria’s Victorian Empax Clinic Set for Q2 2026 Launch with Key Milestones Achieved
24 Mar 2026 ·Operational Update ·75
Emyria Posts $1.2M Revenue Growth as Clinic Network Expands and PTSD Outcomes ImpressMedium
Emyria reports $1.2M revenue growth, clinic expansions, and advances in psychedelic therapy programs
5 May 2026 ·Investor Presentation ·75
Emyria Resolves Prescriber Bottleneck and Recruits Therapists to Expand Q4 Dosing CapacityMedium
Emyria resolves prescriber bottleneck and recruits therapists to expand Q4 dosing capacity
20 Aug 2026 ·Operational Update ·75
Emyria Reports Encouraging Early Results in Treatment-Resistant Depression ProgramMedium
Emyria reports encouraging early results in treatment-resistant depression program
24 June 2026 ·Clinical Trial Results ·75
Emyria Boosts Perth Clinic Capacity Ahead of National Expansion in 2026Medium
Emyria expands Perth clinic capacity and therapist approvals ahead of national clinical growth in 2026
11 Dec 2025 ·Operational Update ·75
Not Assessed Low Score, or missing data
0

No articles in this tier for the last 12 months.